Novavax

Novavax, Inc., is an American biotechnology company based in Gaithersburg, Maryland that creates vaccines to fight against serious infectious diseases. Before to 2020, company scientists developed experimental vaccines for Ebola, influenza, respiratory syncytial virus (RSV), and other emerging infectious diseases. 
During 2020, however, the company redirected its efforts to focus on development and approval of a vaccine for COVID-19.